EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN
The article is dedicated to the use of immunomodulators in children, conditions, at which the prescription of this group of drugs is reasonable, action mechanism and also efficacy are given. In particular, the authors give their observation results for a group of HPV-infected children vaccinated by...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2013-01-01
|
| Series: | Педиатрическая фармакология |
| Subjects: | |
| Online Access: | https://www.pedpharma.ru/jour/article/view/255 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The article is dedicated to the use of immunomodulators in children, conditions, at which the prescription of this group of drugs is reasonable, action mechanism and also efficacy are given. In particular, the authors give their observation results for a group of HPV-infected children vaccinated by live vaccines (rubella and divalent measles-parotitis vaccine) together with pidotimod usage. No undesirable phenomena were registered in the postvaccinal period. Dynamics of immunological indicators did not change significantly. Seroconversion level of measles antibodies totaled 100% by the 30th observation day. |
|---|---|
| ISSN: | 1727-5776 2500-3089 |